aaavl2821 的提交内容

Biotech VC funding down 60% in March

Biotech investors are slashing exposure to IPOs

Big investors slashing exposure to early-stage biotech stocks

Biotech from Bust to Boom

Biotech from Bust to Boom

Case study in analyzing clinical trial risk [video]

A framework for analyzing biotech clinical trial risk [video]

The Biotech IPO Crunch

Was FDA's review of aducanumab biased? [video]

Valuations of biotech startups from Series A to IPO

Analyzing clinical data of a controversial Alzheimer's drug [video]

Intro to interpreting clinical data for biotech investing [video]

Intro to Biotech DCF Analysis [video]

Intro to Valuation in Biotech [video]

The VC power law: biotech vs. tech

Biotech investing basics: measuring value

The VC power law: tech vs. biotech

Biotech investing basics: value creation in biotech [video]

Expected returns for biotech venture investments

Expected returns for biotech venture investments

The new generation of biotech seed funds

Biotech Seed Investors

Biotech startup analysis: Korro's mRNA editing and Graphite's gene editing

Fighting “Eroom's Law” [video]

Finding ideas for biotech startups [video]

Interview with Max Altman, co-founder of Apollo [video]

Biopharma Startup Funding Dashboard

Top biotech VCs, 2018-2020

AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction

Show HN: Biotech Startup Database